New details about the way this important molecule takes on tasks beyond sensing calcium could spur the develop of new drugs for breast cancer and other diseases.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
Ancient parts of the brain may hold secrets that help explain the drive to eat and how eating may affect brain health. Sabrina Diano, the new Institute of Human Nutrition director, is investigating.
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
The most detailed analysis to date of CRISPR genome editing in human embryos finds a significant risk of chromosomal abnormalities when using the technique at the earliest stage of human development.
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
Columbia/NYSPI researchers are examining how millions of college students are addressing COVID-19 challenges, including academic/life plans, decision-making, substance use, and mental well-being.
Cardiovascular disease is the No. 1 cause of maternal mortality in the United States, but a new study suggests specialized cardio-obstetrics teams may improve outcomes.
New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.
Using stem cells from pig fat, a team led by Columbia engineers grew anatomically precise jawbones, including associated cartilage, that successfully replaced the pig's temporomandibular joint (TMJ).